Asacpharma is a Spanish pharmaceutical group comprising:

ESPECIALIDADES FARMACÉUTICAS CENTRUM, S.A.
Centrum is a production plant for medicines and cosmetics that has Certificates of Good Manufacturing Practice (GMP) for both.

ASAC PHARMACEUTICAL INMUNOLOGY S.A.
Production plant for biological medicines and active substances with the "Certificate of compliance with good manufacturing practice for hyposensitising vaccines and skin test diagnostics".

The company is made up of a consolidated staff of approximately 400 people whose daily work aims to improve the health and quality of life of more than one million patients who benefit from our treatments every year, both domestically and abroad.

Asacpharma has five manufacturing plants to carry out its activity: two in Alicante, one in Murcia, one in Casablanca (Morocco) and another in Sao Paulo (Brazil). Furthermore, although its head offices are located in Alicante, it has representative offices in Madrid and in the main capitals of Latin America.

As a company with international projection, we distribute our products in more than 40 countries through seven subsidiaries and an international distribution network. Specifically, Asacpharma has six active companies in Latin America (Brazil, Mexico, Chile, Colombia, Guatemala and Paraguay) and one in Morocco. Our effort and work on the international level, led Asacpharma to be distinguished with the NOVA Award for Internationalization in 1998.

The NOVA Award is not the only one of the company’s many milestones. Thanks to the group’s strong research vocation, we have carried out a number of R & D projects. One of the most important was Project IBEROEKA 003: "Screening and isolation of pharmacologically active principles in Ibero-American plants", with which we became pioneers in the research of medicinal plants.

Moreover, we are proud to be part of BIOVAL, an Association of Companies and Entities of the BIO sector that encompasses the Biotechnology, Biomedicine and Bio-economy of the Valencian Community.

"An investment in knowledge always pays the best interest”. -Benjamin Franklin

For Asacpharma, the patient is our priority. Through our vaccines, medicines, food supplements and cosmetic products, we help to prevent and/or treat those who need it.

In our company, the patient always comes first. Through our vaccines, medicines and cosmetics, we help provide prevention and/or treatment for those who need it.

Our main mission is to become a national benchmark with a growing presence on the international market, recognized for the level of excellence and quality of our products and processes. Furthermore, we fully intend to become leaders in each and every therapeutic area in which we work, in order to be recognized as the best company to work with and invest in. At the same time, we have to build a sustainable business that provides innovative solutions, which is why our business strategy is based on different aspects:

• Increased innovation in R & D

We intend to become an internationally recognized pharmaceutical laboratory, its activity based on research and development of products that provide quality health solutions. The constantly changing dynamics of the pharmaceutical industry and scientific advances have made it necessary to diversify and seek alliances and acquisitions to grow the company. This has made it vital to establish collaborations on R & D projects with companies and/or universities (i.e., co-development).

• Own and third party manufacturing of vaccines, dermatological products and food supplements.

We actively seek out business opportunities for commercializing third-party products ("In- Licensing ") in Spain, Morocco and Latin America, in terms of both exclusivity and semi- exclusivity. This means that ASACPHARMA is systematically present at the main national and international events of Business Development.

Therefore, we believe our company contributes significantly to research and development, thereby making treatments increasingly specific and effective. But it is not only our work in R & D that makes our company grow; the excellent management of the company must also be taken into account, along with Asacpharma’s firm commitment with its employees, customers and suppliers.

Through our research and development of pharmaceutical and cosmetic products, at Asacpharma we seek to take care of people, both inside and out. This is the same aim of our Human Resources Department.
We are aware of the fact that our most valuable asset is our team, which is why we strive to attract, motivate and develop competent professionals.
We endeavor to form a solid, capable team and a dynamic work environment. First and foremost, however, we are a professional and human group, so the following principles take on special relevance:

• Professional development and growth
At Asacpharma we strive to enhance the professional development of our team, ensuring optimal learning for all our employees.
We also develop training plans that allow constant renewal and innovation.

• Flexibility
Asacpharma is committed to adaptability as a fundamental means for striking a balance between family and work life.
Our starting point is a new work culture that balances the work and personal spheres based on flexibility, respect and mutual commitment.
This principle focuses on holding onto talent and provides our team with a better quality of life.

If you’re interested in joining our team, send us an email with your contact information and curriculum vitae through our CONTACTpage.


Carla Navarro
Head of Human Resources at Asacpharma.
You can also reach us at: rrhh@asac.net


Legal note: ASAC COMPAÑÍA DE BIOTECNOLOGÍA E INVESTIGACIÓN S.A. (hereinafter ASACPHARMA), provista de CIF A-53027942, hereby informs you that, in accordance with Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of individuals with regard to the processing of personal data and on the free movement of such data, that the personal data provided and collected in this job application or CV submission will be processed and automatically included in the personal data files under the responsibility of ASACPHARMA, that the personal data provided and collected in this job application or CV submission, will be processed and automatically included in the personal data files under the responsibility of ASACPHARMA, where personal data are collected and stored for the sole purpose of taking part in the personnel selection, job vacancies and recruitment processes that are carried out.
You consent to the processing of your personal data for the above-mentioned purposes. In the event of any modification to your personal data, please inform us in writing for the sole purpose of keeping your job application and/or curriculum vitae up to date.
ASACPHARMA guarantees the appropriate use of the information and, in particular, the absolute confidentiality of the personal data contained in our files, as well as full compliance with the obligations regarding the protection of personal data.
The owner of the personal data expressly and unequivocally consents to the transfer of his/her personal data only to the ASACPHARMA Group Companies interested in certain job profiles.
In accordance with the provisions of Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of individuals with regard to the processing of personal data and on the free movement of such data, ASACPHARMA undertakes to respect your confidentiality in the processing of your personal data, and informs you that you have the right to exercise your rights of access, rectification, portability and deletion of your data and to limit or oppose the processing of your personal data by sending a written request, enclosing a photocopy of your ID card, addressed to ASAC COMPAÑÍA DE BIOTECNOLOGÍA E INVESTIGACIÓN S.A., with address at: Calle Sagitario, 14, CP 03006 Alicante (España).
And if you consider that the processing does not comply with the regulations in force, you may lodge a complaint with the supervisory authority (Spanish Data Protection Agency), via its website: https://www.aepd.es/es

ESPECIALIDADES FARMACÉUTICAS CENTRUM, S.A. CARRIED OUT AND FINISHED VARIOUS R+D+i PROJECTS:

• 2009: Controlled single-center, double-blind phase IV pilot clinical trial on the effects of turmeric extract centrum standardized to 12 % curcumin + local phototherapy with visible light in adults diagnosed with psoriasis in moderate-severe plaque of at least 6 months’ evolution. EudraCT Number 2008-006420-65.

• 2010: Development of a blue visible light cabin for the phototherapeutic + drug treatment of plaque psoriasis.

• 2011: Pilot clinical trial, phase IV, to evaluate the efficacy of Centrum Turmeric extract plus phototherapy with blue light versus Oxoralen + UVA in patients with moderate to severe psoriasis. EudraCT Number 2010-024158-13.

OTHER PROJECTS For information on other R+D projects, contact IDi@asac.net.

ESPECIALIDADES FARMACÉUTICAS CENTRUM, S.A. (Alicante)

Especialidades farmacéuticas Centrum is a production plant for medicines, cosmetics and food supplements, which has the Certificates of Good Manufacturing Practice (GMP) for both. This production site not only manufactures for the company, but also performs manufacturing tasks for third parties.

The pharmaceutical formats that are manufactured in Centrum for the distribution of medicines are: hard capsules, liquids for external and internal use, semisolids (emulsion creams) and tablets.

In addition, for cosmetics, Centrum manufactures products for the care and cleaning of the skin, hair and scalp, as well as sunscreens. The pharmaceutical formats of our cosmetics are: solutions, suspensions, emulsions and gels packed in plastic and aluminum tubes (formats from 10 to 200 ml) or in bottles (50 to 750 ml).

ASAC PHARMACEUTICAL INMUNOLOGY S.A. (Alicante)

This facility produces biological medicines and active substances and has the certificate of compliance with standards for the correct manufacture of hyposensitizing vaccines and skin test diagnostics.

Asac Pharmaceutical Immunology manufactures a wide variety of products, such as skin tests (for allergy diagnosis), lyophilized allergenic extracts, bacterial suspensions and lyophilized and liquid allergenic bulks.

We also produce vaccines at the Alicante plant, such as individualized sublingual bacterial vaccines and sublingual immunological individualized vaccines. Moreover, Asac Pharmaceutical Immunology facilities also carry out mite culture.

ESPECIALIDADES FARMACÉUTICAS CENTRUM, S.A. Sucina (Murcia)

We have a facility in Murcia (Spain) for the extraction of vegetable principles in Murcia, from which we develop and manufacture exclusive extracts for third parties, as per to the needs of the client. It is an integral unit of solid-liquid and liquid-liquid extraction, and is completely ecological, since it has a closed, complete circuit design without releasing any harmful elements into the environment.

Therefore, Especialidades Farmacéuticas Centrum is dedicated to the research, development and manufacture of extracts of medicinal plants for applications in the pharmaceutical, cosmetic, food and nutraceutical industries.

LABORATORIES PHARMACEUTIQUES IBERMA. Has Soualem, Settat (Casablanca - Marruecos)

Another of our drug production plants is located in Casablanca. This Moroccan plant also has a Certificate of Compliance for correct manufacture of medicines issued by the AEMPS Like the Centrum plant in Alicante, Iberma also manufactures for third parties. In addition, Iberma has agreements with different Spanish and Portuguese laboratories.

The pharmaceutical formats elaborated here are: hard capsules, liquids for external and internal use, semisolids (creams, emulsions, suppositories, ovules) and coated and powdered tablets.

IPI ASAC do BRASIL Ltda. (Sao Paulo-Brasil)

We have another production plant in Brazil for biological medicines and active substances with the relevant certificate for this activity. It can be considered analogous to the Asac production center Pharmaceutical Immunology since it also performs skin tests and makes individualized and immunological vaccines.